Innate Pharma SA Noncurrent Receivables
Innate Pharma SA (IPHYF) had Noncurrent Receivables of EUR 251.00 thousand as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Receivables
ifrs-full:NoncurrentReceivables · last filed 2026-04-01
- 2025-12-31: Noncurrent Receivables 251.00K EUR.
- 2025-06-30: Noncurrent Receivables 12.04M EUR.
- 2024-12-31: Noncurrent Receivables 9.33M EUR.
- 2024-06-30: Noncurrent Receivables 14.48M EUR.
| Period end | Noncurrent Receivables |
|---|---|
| 2025-12-31 | 251.00K EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 12.04M EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 9.33M EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 14.48M EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 10.55M EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 880.00K EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 14.10M EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 13.08M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 29.82M EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 34.75M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 29.82M EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 16.74M EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-04-27 |